Next-generation risk assessment of chemicals - Rolling out a human-centric testing strategy to drive 3R implementation: The RISK-HUNT3R project perspective.

H2020 project RISK-HUNT3R new approach methodologies next-generation risk assessment

Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2022
Historique:
received: 07 04 2022
accepted: 07 04 2022
entrez: 11 4 2022
pubmed: 12 4 2022
medline: 27 7 2022
Statut: ppublish

Résumé

In many industrial sectors, there is a need for reliable ways to evaluate the safety of chemicals with methods anchored to human biology and pathology. For this purpose, many animal-free new approach methods (NAMs) have been developed and implemented in various stages of risk assessment. Now it is time to assemble individual NAMs into a comprehensive next-generation risk assessment (NGRA) strategy. The European Horizon 2020 RISK-HUNT3R project (Risk assessment of chemicals integrating human-centric next-generation testing strategies promoting the 3Rs) has been designed to promote a combination of computational toxicology, in vitro toxicology, and systems biology. It is anticipated that this approach will lead to faster and more accurate risk assessment procedures. The RISK-HUNT3R NGRA strategy will be developed to address the implementation of a comprehensive NAM toolbox into the regulatory framework. Critical conceptual approaches of the project include i) the integration of human-relevant data on biotransformation and elimination, ii) the translation of high-content mode-of-action datasets into predictions of adverse outcomes, iii) development of quantitative adverse outcome pathways (qAOPs), and iv) quantification of uncertainties associated with the predictions based on NGRA strategies. Many of the project steps will be used iteratively to generate datasets with sufficient quality and certainty for NGRA. Scientists and regulators will work together on case studies to evaluate practical applicability of NAMs and strategies to combine information therefrom. Here we delineate how the strategy will be deployed to establish an overall NGRA framework for chemicals, pesticides, food additives, and drugs.

Identifiants

pubmed: 35404467
doi: 10.14573/altex.2204051
doi:

Substances chimiques

Pesticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

419–426

Auteurs

Giorgia Pallocca (G)

CAAT-Europe, University of Konstanz, Konstanz, Germany.

Martijn J Moné (MJ)

Cancer Therapeutics and Drug Safety group at the Division of Drug Discovery & Safety, University Leiden, Leiden, The Netherlands.

Hennicke Kamp (H)

BASF Metabolome Solutions GmbH, Berlin, Germany.

Mirjam Luijten (M)

RIVM, Bilthoven, The Netherlands.

Bob Van de Water (B)

Cancer Therapeutics and Drug Safety group at the Division of Drug Discovery & Safety, University Leiden, Leiden, The Netherlands.

Marcel Leist (M)

CAAT-Europe, University of Konstanz, Konstanz, Germany.
In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH